Pre-transplant donor HLA-specific antibodies: Characteristics causing detrimental effects on survival after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 33, Issue 10, 2014, Pages 1074-1082

  Smith, John D ^a   Ibrahim, Mohamed W ^a   Newell, Helen ^a   Danskine, Anna J ^a   Soresi, Simona ^a   Burke, Margaret M ^a   Rose, Marlene L ^a   Carby, Martin ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

antibodies lung; donor specific; HLA Luminex xmap; MFI; Pre transplant; transplantation

Indexed keywords

AZATHIOPRINE; COMPLEMENT; COMPLEMENT COMPONENT C4D; CYCLOSPORIN; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; ANTIBODY; HLA ANTIGEN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT FIXATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG CYSTIC FIBROSIS; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ORGAN DONOR; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SERUM; STEROID THERAPY; ALLOGRAFT; BLOOD; DONOR; GRAFT REJECTION; IMMUNOLOGY; INCIDENCE; LUNG DISEASES; MORTALITY; MULTIVARIATE ANALYSIS; RISK FACTOR; SURVIVAL RATE;

ADULT; ALLOGRAFTS; ANTIBODIES; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; INCIDENCE; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TISSUE DONORS;

EID: 84908122182     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.02.033     Document Type: Article

References (34)

1. R. Patel, and P.I. Terasaki Significance of the positive crossmatch test in kidney transplantation N Engl J Med 280 1969 735 739
2. J.D. Smith, A.J. Danskine, and R.M. Laylor The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation Transpl Immunol 1 1993 60 65
3. J.D. Smith, I.M. Hamour, and N.R. Banner C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation Am J Transplant 7 2007 2809
4. P.M. Eckman, M. Hanna, and D.O. Taylor Management of the sensitized adult heart transplant candidate Clin Transplant 24 2010 726 734
5. R. Yanagida, L.S. Czer, and N.L. Reinsmoen Impact of virtual cross match on waiting times for heart transplantation Ann Thorac Surg 92 2011 2104 2110
6. V. Aubert, J.P. Venetz, and G. Pantaleo Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant Hum Immunol 70 2009 580 583
7. E.M. van den Berg-Loonen, and E.V. Billen Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients Transplantation 85 2008 1086 1090
8. A.A. Zachary, J.T. Sholander, and J.A. Houp Using real data for a virtual crossmatch Hum Immunol 70 2009 574 579
9. R.A. Bray, and H.M. Gebel Strategies for human leukocyte antigen antibody detection Curr Opin Organ Transplant 14 2009 392 397
10. E.F. Reed, P. Rao, and Z. Zhang Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation Am J Transplant 13 2013 3050 3051
11. D.B. Tyan New approaches for detecting complement-fixing antibodies Curr Opin Organ Transplant 17 2012 409 415
12. M. Estenne, J.R. Maurer, and A. Boehler Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 2002 297 310
13. S. Stewart, M.C. Fishbein, and G.I. Snell Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection J Heart Lung Transplant 26 2007 1229 1242
14. A. Gupta, V. Iveson, and M. Varagunam Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant? Transplantation 85 2008 1200 1204
15. E.M. Gibney, L.R. Cagle, and B. Freed Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification Nephrol Dial Transplant 21 2006 2625 2629
16. O. Brugière, C. Suberbielle, and G. Thabut Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay Transplantation 15 2013 761 765
17. G. Opelz, B. Dohler, and C. Susal Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study Hum Immunol 70 2009 627 630
18. G. Berry, M. Burke, and C. Andersen Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT J Heart Lung Transplant 32 2013 14 21
19. S.A. Yousem, and A. Zeevi The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies Am J Surg Pathol 36 2012 987 992
20. M.M. DeNicola, S.S. Weigt, and J.A. Belperio Pathologic findings in lung allografts with anti-HLA antibodies J Heart Lung Transplant 32 2013 326 332
21. C.A. Witt, J.P. Gaut, and R.D. Yusen Acute antibody-mediated rejection after lung transplantation J Heart Lung Transplant 32 2013 1034 1040
22. A.M. Patel, C. Pancoska, and S. Mulgaonkar Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches Am J Transplant 7 2007 2371 2377
23. M. Wahrmann, M. Exner, and B. Haidbauer [C4d]FlowPRA screening - a specific assay for selective detection of complement-activating anti-HLA alloantibodies Hum Immunol 66 2005 526 534
24. G. Bartel, M. Wahrmann, and M. Exner In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts Am J Transplant 8 2008 41 49
25. L.D. Snyder, Z. Wang, and D.F. Chen Implications for human leukocyte antigen antibodies after lung transplantation: a 10 year experience in 441 patients Chest 144 2013 226 233
26. R.R. Hachem, R.D. Yusen, and B.F. Meyers Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation J Heart Lung Transplant 29 2010 973 980
27. A.I. Scott, L.D. Sharples, and S. Stewart Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies Drugs 65 2005 761 771
28. M.A. Smith, S. Sundaresan, and T. Mohanakumar Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome J Thorac Cardiovasc Surg 116 1998 812 820
29. W. Chalermskulrat, I.P. Neuringer, and J.L. Schmitz Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation Chest 123 2003 1825 1831
30. O. Brugière, G. Thabut, and C. Suberbielle Relative impact of human leukocyte antigen mismatching and graft ischemic time after lung transplantation J Heart Lung Transplant 27 2008 628 634
31. C. Gutierrez, S. Al-Faifi, and C. Chaparro The effect of recipient's age on lung transplant outcome Am J Transplant 7 2007 1271 1277
32. S.A. Hennessy, T. Hranjec, and B.R. Swenson Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation Ann Thorac Surg 89 2010 1555 1562
33. J. Patel, M. Everly, and D. Chang Reduction of alloantibodies via proteasome inhibition in cardiac transplantation J Heart Lung Transplant 30 2011 1320 1326
34. D. Bucin, R. Gustafsson, and B. Ekmehag Desensitization and heart transplantation of a patient with high levels of donor-reactive anti-human leukocyte antigen antibodies Transplantation 90 2010 1220 1225